179 related articles for article (PubMed ID: 15239334)
21. Cyclooxygenase 2: from inflammation to carcinogenesis.
Ristimäki A
Novartis Found Symp; 2004; 256():215-21; discussion 221-6, 259-69. PubMed ID: 15027493
[TBL] [Abstract][Full Text] [Related]
22. COX-2: a molecular target for colorectal cancer prevention.
Brown JR; DuBois RN
J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention.
Dannenberg AJ; Lippman SM; Mann JR; Subbaramaiah K; DuBois RN
J Clin Oncol; 2005 Jan; 23(2):254-66. PubMed ID: 15637389
[TBL] [Abstract][Full Text] [Related]
24. [Cyclooxygenase 2 and breast cancer. From biological concepts to therapeutic trials].
Guastalla JP; Bachelot T; Ray-Coquard I
Bull Cancer; 2004 May; 91 Spec No():S99-108. PubMed ID: 15239337
[TBL] [Abstract][Full Text] [Related]
25. Thalidomide, cyclooxygenase-2, and angiogenesis: potential for therapy.
Onn A; Tseng JE; Herbst RS
Clin Cancer Res; 2001 Nov; 7(11):3311-3. PubMed ID: 11705841
[No Abstract] [Full Text] [Related]
26. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention.
Chun KS; Surh YJ
Biochem Pharmacol; 2004 Sep; 68(6):1089-100. PubMed ID: 15313405
[TBL] [Abstract][Full Text] [Related]
27. Multifaceted roles of cyclooxygenase-2 in lung cancer.
Riedl K; Krysan K; Põld M; Dalwadi H; Heuze-Vourc'h N; Dohadwala M; Liu M; Cui X; Figlin R; Mao JT; Strieter R; Sharma S; Dubinett SM
Drug Resist Updat; 2004 Jun; 7(3):169-84. PubMed ID: 15296859
[TBL] [Abstract][Full Text] [Related]
28. COX2-alternatives and GI protection.
Med Lett Drugs Ther; 2004 Nov; 46(1195):91-2. PubMed ID: 15534567
[No Abstract] [Full Text] [Related]
29. [Potential pro-thrombotic effects of cyclooxygenase-2. inhibitors Two cases pf myocardial infarction].
Thuaire C; Mankoubi L; Rangé G; Roussel L; Belfaqih H; el Khayef L; Belghit A; Charaf M; Albert F
Arch Mal Coeur Vaiss; 2003 Jun; 96(6):683-5. PubMed ID: 12868352
[TBL] [Abstract][Full Text] [Related]
30. COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer.
Liao Z; Milas L
Expert Rev Anticancer Ther; 2004 Aug; 4(4):543-60. PubMed ID: 15270659
[TBL] [Abstract][Full Text] [Related]
31. [Analgesic effects of cyclooxygenase 2 inhibitors].
Jayr C
Bull Cancer; 2004 May; 91 Spec No():S125-31. PubMed ID: 15239341
[TBL] [Abstract][Full Text] [Related]
32. Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?
Gasparini G; Longo R; Sarmiento R; Morabito A
Lancet Oncol; 2003 Oct; 4(10):605-15. PubMed ID: 14554238
[TBL] [Abstract][Full Text] [Related]
33. Role of chemopreventive agents in cancer therapy.
Dorai T; Aggarwal BB
Cancer Lett; 2004 Nov; 215(2):129-40. PubMed ID: 15488631
[TBL] [Abstract][Full Text] [Related]
34. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
[TBL] [Abstract][Full Text] [Related]
35. Means, responders, and meaning: evaluation of clinical trials in osteoarthritis.
Schnitzer TJ
Arthritis Rheum; 2003 Nov; 48(11):3001-3. PubMed ID: 14613258
[No Abstract] [Full Text] [Related]
36. Cyclooxygenase-2 as a target for anticancer drug development.
Méric JB; Rottey S; Olaussen K; Soria JC; Khayat D; Rixe O; Spano JP
Crit Rev Oncol Hematol; 2006 Jul; 59(1):51-64. PubMed ID: 16531064
[TBL] [Abstract][Full Text] [Related]
37. Chemoprevention controversies continue.
Lebeau D
Lancet; 1998 Nov; 352(9141):1683. PubMed ID: 9853452
[No Abstract] [Full Text] [Related]
38. [COX and study of cancer therapy].
Yamada N; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1147-51. PubMed ID: 15332534
[TBL] [Abstract][Full Text] [Related]
39. Endothelial COX-2 inhibition: possible relevance for hypertension and cardiovascular risk?
Stiller CO; Hjemdahl P
J Hypertens; 2003 Sep; 21(9):1615-8. PubMed ID: 12923388
[No Abstract] [Full Text] [Related]
40. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor.
Hasegawa K; Ohashi Y; Ishikawa K; Yasue A; Kato R; Achiwa Y; Nishio E; Udagawa Y
Int J Oncol; 2005 May; 26(5):1419-28. PubMed ID: 15809736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
